36 results
DEFA14A
ZNTL
Zentalis Pharmaceuticals Inc
29 May 24
Additional proxy soliciting materials
7:16am
the University of Oklahoma. Dr. Walker also completed the Stanford Graduate School of Business LGBTQ Executive Leadership Program in 2017. We believe
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
27 Feb 24
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
7:04am
malignancy in 2026.
Corporate Updates
Strengthened Leadership Team with the addition of Diana Hausman, M.D. as Chief Medical Officer, and Kyle
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
25 Jan 24
Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments
7:03am
. “Carrie built an incredibly talented team during her time with us. I would like to thank Carrie for her leadership and contributions to advancing
8-K
EX-99.1
anri1v3 3pz0
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
EX-99.1
0m6drdmws7zex9f9
9 Aug 23
Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
7:03am
PRE 14A
rs2ftvn
18 Apr 23
Preliminary proxy
4:30pm
8-K
EX-99.1
1q29j0om84d7iux
9 Nov 22
Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
7:04am
8-K
EX-99.1
ev0 lc2iklss07
9 Aug 22
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
12:00am